L. Hansen Carl - Nov 18, 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Tryn Stimart, attorney-in-fact
Stock symbol: ABCL
Transactions as of: Nov 18, 2022
Transactions value $: $151,538
Form type: 4
Date filed: 11/21/2022, 08:36 PM
Previous filing: Aug 22, 2022
Next filing: Dec 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Options Exercise	$152K	+56.1K	+14.29%	$2.70	449K	Nov 18, 2022	Direct
holding	ABCL	Common Shares						55.8M	Nov 18, 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Options Exercise	$0	-56.1K	-0.98%	$0.00	5.69M	Nov 18, 2022	Common Shares	56.1K	$2.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
F2	The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.